Shoe Carnival Q4 GAAP Net Income Rises

Shoe Carnival, Inc. (SCVL) reported fourth quarter net income and EPS on a GAAP basis of $21.6 million and $0.79. For the fourth quarter of prior year, net income and EPS were at $20.6 million, and $0.72, respectively. Excluding the Shoe Station acquisition-related charges incurred in fourth quarter 2021, fourth quarter 2021 adjusted net income and adjusted EPS were $23.8 million and $0.83, respectively.

On average, three analysts polled by Thomson Reuters expected the company to report profit per share of $0.80, for the quarter. Analysts' estimates typically exclude special items.

Fourth quarter net sales were $290.8 million, decreased 7.2%, compared to a stimulus-elevated fourth quarter 2021. Analysts on average had estimated $309.59 million in revenue.

For fiscal 2023, the company expects: EPS of $3.96 to $4.20; and net sales of $1.26 billion to $1.32 billion. Comparable store sales are projected to be in between a decline of 2% and growth of 2%. The annual guidance includes the expectation of a mid-single digit decline in net sales in first quarter 2023.

The Board of Directors approved an 11 percent increase to the quarterly cash
dividend to $0.10 per share from $0.09. The quarterly cash dividend will be paid on April 17, 2023 to shareholders of record as of the close of business on April 3, 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT